FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Miller

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Procedures

Physiology

Anatomy

Bone and Bones

Co-author Network

Publications

TOP 3
Michael R McClung; Michael A Bolognese; B Ding; M L Geller; E Michael Lewiecki; M Peacock; E Rockabrand; R B Wagman; R L Weinstein; Paul D Miller
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial.
Eric Orwoll; Jean-Yves Reginster; Suresh Siddhanti; Christence S Teglbjærg; Rachel B Wagman; Yu-Ching Yang; Osten Ljunggren; Bo Abrahamsen; Michael A Bolognese; Henry G Bone; Roland Chapurlat; Edward Czerwinski; Andreas Grauer; Ugis Gruntmanis; Jesse W Hall; David L Kendler; Alan Kivitz; Bente L Langdahl; E Michael Lewiecki; Michael R McClung; Paul D Miller; Steven Boonen
A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.
David W Dempster; David A Hanley; Boris Janos; David L Kendler; E Michael Lewiecki; Robert Lindsay; Paul D Miller; D. Sudhaker Rao; Robert R Recker; Christopher P Recknor; Valerie A Ruff; Neil Binkley; Michael A Bolognese; Jacques P Brown; Xiaohai Wan; Grattan C Woodson; Hua Zhou; Kathleen A Taylor
Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Miller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael R McClung; Michael A Bolognese; B Ding; M L Geller; E Michael Lewiecki; M Peacock; E Rockabrand; R B Wagman; R L Weinstein; Paul D Miller
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2013;24(1):227-35.
2012: Eric Orwoll; Jean-Yves Reginster; Suresh Siddhanti; Christence S Teglbjærg; Rachel B Wagman; Yu-Ching Yang; Osten Ljunggren; Bo Abrahamsen; Michael A Bolognese; Henry G Bone; Roland Chapurlat; Edward Czerwinski; Andreas Grauer; Ugis Gruntmanis; Jesse W Hall; David L Kendler; Alan Kivitz; Bente L Langdahl; E Michael Lewiecki; Michael R McClung; Paul D Miller; Steven Boonen
A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.
The Journal of clinical endocrinology and metabolism 2012;97(9):3161-9.
2012: David W Dempster; David A Hanley; Boris Janos; David L Kendler; E Michael Lewiecki; Robert Lindsay; Paul D Miller; D. Sudhaker Rao; Robert R Recker; Christopher P Recknor; Valerie A Ruff; Neil Binkley; Michael A Bolognese; Jacques P Brown; Xiaohai Wan; Grattan C Woodson; Hua Zhou; Kathleen A Taylor
Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial.
The Journal of clinical endocrinology and metabolism 2012;97(8):2799-808.
2012: John P Bilezikian; Joao Lindolfo Borges; Bruno Muzzi Camargos; Didier Hans; E Michael Lewiecki; Paul D Miller; Cristiano A F Zerbini; Michael R McClung
In Memoriam: Sergio Ragi-Eis, MD, CCD, CDT (April 8, 1962–February 22, 2012).
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2012;15(3):257-9.
2012: Paul D Miller; Robert R Recker; Jean-Yves Reginster; B J Riis; Jacob A Stakkestad; E Czerwinski; A Kenwright; R Lorenc; Daiva Masanauskaite; P Lakatos
Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2012;23(6):1747-56.
2012: E Michael Lewiecki; Paul D Miller; Andrew J Laster; John P Bilezikian
More bone density testing is needed, not less.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(4):739-42.
2012: E Michael Lewiecki; Eugene V McCloskey; Paul D Miller; Sarah L Morgan; Eric S Orwoll; John P Bilezikian; Lawrence G Jankowski; John T Potts
Proceedings of the 2011 Santa Fe Bone symposium.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2012;15(1):1-20.
2011: E Michael Lewiecki; Roman R Lorenc; Basel K Masri; Paul D Miller; Alireza Moayyeri; Jonathan D Adachi; Judith E Adams; Robert A Adler; Douglas Charles Bauer; Glen M Blake; Patricia Clark; Juliet E Compston; Adolfo Diez-Perez; Didier Hans; Robert G Josse; John A Kanis; David L Kendler; Aliya A Khan; Marc-Antoine Krieg; William D Leslie
Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2011;14(3):226-36.
2011: E Michael Lewiecki; Paul D Miller; Jonathan D Adachi; Judith E Adams; Juliet E Compston; John A Kanis; William D Leslie
FRAX(®) Bone Mineral Density Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2011;14(3):223-5.
2011: Henry G Bone; Michael A Bolognese; Chui Kin Yuen; David L Kendler; Paul D Miller; Yu-Ching Yang; luanda grazette; Javier San Martin; J Christopher Gallagher
Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass.
The Journal of clinical endocrinology and metabolism 2011;96(4):972-80.
2011: Felicia Cosman; Erik Fink Eriksen; Chris Recknor; Paul D Miller; Núria Guañabens; Christian Kasperk; Philemon Papanastasiou; Aimee Readie; Hanumantha Rao; Jürg A Gasser; Christina Bucci-Rechtweg; Steven Boonen
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(3):503-11.
2011: E Michael Lewiecki; John P Bilezikian; Sundeep Khosla; Robert Marcus; Michael R McClung; Paul D Miller; Nelson B Watts; Michael Maricic
Osteoporosis update from the 2010 santa fe bone symposium.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2011;14(1):1-21.
2010: Julie Satterwhite; Michael Heathman; Paul D Miller; Fernando Marín; Emmett V Glass; Harald Dobnig
Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis.
Calcified tissue international 2010;87(6):485-92.
2010: E Michael Lewiecki; John P Bilezikian; Andrew J Laster; Paul D Miller; Robert R Recker; R Graham G Russell; Michael P Whyte
2009 Santa Fe Bone symposium.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2010;13(1):1-9.
2009: Paul D Miller
Fragility fractures in chronic kidney disease: an opinion-based approach.
Cleveland Clinic journal of medicine 2009;76(12):715-23.
2009: Elizabeth Barrett-Connor; T W Weiss; C A McHorney; Paul D Miller; Ethel S Siris
Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA).
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2009;20(5):715-22.
2009: E Michael Lewiecki; Sandord Baim; John P Bilezikian; Ana Munoz; Meryl Leboff; Paul D Miller
2008 Santa Fe Bone Symposium: update on osteoporosis.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2009;12(2):135-57.
2009: Sandord Baim; Paul D Miller
Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;24(4):561-74.
2009: Paul D Miller
Diagnosis and treatment of osteoporosis in chronic renal disease.
Seminars in nephrology 2009;29(2):144-55.
2009: Paul D Miller
Denosumab: anti-RANKL antibody.
Current osteoporosis reports 2009;7(1):18-22.
2009: Michael R McClung; Michael A Bolognese; Farhad Sedarati; Robert R Recker; Paul D Miller
Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss.
Bone 2009;44(3):418-22.
2008: Paul D Miller; P Ward; T Pfister; C Leigh; J J Body
Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review.
Clinical and experimental rheumatology 2008;26(6):1125-33.
2008: Paul D Miller
The role of bone biopsy in patients with chronic renal failure.
Clinical journal of the American Society of Nephrology : CJASN 2008;3 Suppl 3():S140-50.
2008: Bo Fan; E Michael Lewiecki; M Sherman; Ying Lu; Paul D Miller; Harry K Genant; John A Shepherd
Improved precision with Hologic Apex software.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(11):1597-602.
2008: Paul D Miller; Pierre D Delmas; Robert Lindsay; Nelson B Watts; Marjorie Luckey; Jonathan Adachi; Kenneth G Saag; Susan L Greenspan; Ego Seeman; Steven Boonen; Suzanne Meeves; Thomas Lang; John P Bilezikian
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.
The Journal of clinical endocrinology and metabolism 2008;93(10):3785-93.
2008: Michael Pazianas; William A Blumentals; Paul D Miller
Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(6):773-9.
2008: Elizabeth Barrett-Connor; S G Sajjan; Ethel S Siris; Paul D Miller; Ya-Ting Chen; L E Markson
Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA).
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(5):607-13.
2008: E Michael Lewiecki; John P Bilezikian; Cyrus Cooper; Marc C Hochberg; Marjorie M Luckey; Michael Maricic; Paul D Miller
Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2008;11(2):313-24.
2008: Paul D Miller; Arkadi A Chines; Claus Christiansen; Hans Chr. Hoeck; David L Kendler; E Michael Lewiecki; Grattan Woodson; Amy B Levine; Ginger Constantine; Pierre D Delmas
Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(4):525-35.
2008: Steven T Harris; William A Blumentals; Paul D Miller
Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies.
Current medical research and opinion 2008;24(1):237-45.
2008: Paul D Miller; Sol Epstein; Farhad Sedarati; Jean-Yves Reginster
Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study.
Current medical research and opinion 2008;24(1):207-13.
2008: Paul D Miller
Non-vertebral fracture risk reduction with oral bisphosphonates: challenges with interpreting clinical trial data.
Current medical research and opinion 2008;24(1):107-19.
2007: E Michael Lewiecki; Paul D Miller; Michael R McClung; Stanley B Cohen; Michael A Bolognese; Yu Liu; Andrea Wang; Suresh Siddhanti; Lorraine A Fitzpatrick
Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(12):1832-41.
2007: Thomas W Weiss; E S Siris; Elizabeth Barrett-Connor; Paul D Miller; Colleen A McHorney
Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(11):1473-80.
2007: Paul D Miller; John P Bilezikian; Manuel Diaz-Curiel; Peiqi Chen; Fernando Marin; John Krege; Mayme Wong; Robert Marcus
Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide.
The Journal of clinical endocrinology and metabolism 2007;92(9):3535-41.
2007: Ya-Ting Chen; Paul D Miller; Elizabeth Barrett-Connor; Thomas W Weiss; Shiva G Sajjan; E S Siris
An approach for identifying postmenopausal women age 50-64 years at increased short-term risk for osteoporotic fracture.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(9):1287-96.
2007: Peiqi Chen; Paul D Miller; Robert Recker; Heinrich Resch; Asad Rana; Imre Pavo; Adrien Sipos
Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(8):1173-80.
2007: Paul D Miller
Is there a role for bisphosphonates in chronic kidney disease?
Seminars in dialysis 2007;20(3):186-90.
2007: Paul D Miller
Monitoring osteoporosis therapies.
Current osteoporosis reports 2007;5(1):38-43.
2007: Paul D Miller; Elliott N Schwartz; Peiqi Chen; Derek A Misurski; John Krege
Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(1):59-68.
2006: Peiqi Chen; Paul D Miller; Pierre D Delmas; Derek A Misurski; John Krege
Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21(11):1785-90.
2006: E Michael Lewiecki; Bradford Richmond; Paul D Miller
Uses and misuses of quantitative ultrasonography in managing osteoporosis.
Cleveland Clinic journal of medicine 2006;73(8):742-6, 749-52.
2006: Paul D Miller
Guidelines for the diagnosis of osteoporosis: T-scores vs fractures.
Reviews in endocrine & metabolic disorders 2006;7(1-2):75-89.
2006: Jean-Yves Reginster; Silvano Adami; P Lakatos; M Greenwald; Jan J Stepan; Stuart L Silverman; C Christiansen; L Rowell; N Mairon; Bernard Bonvoisin; Marc K Drezner; R Emkey; Dieter Felsenberg; Cyrus Cooper; Pierre D Delmas; Paul D Miller
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.
Annals of the rheumatic diseases 2006;65(5):654-61.
2006: John Krege; Paul D Miller; Leon Lenchik; Derek A Misurski; Peiqi Chen
New or worsening lumbar spine vertebral fractures increase lumbar spine bone mineral density and falsely suggest improved skeletal status.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2006;9(2):144-9.
2006: Michael R McClung; E Michael Lewiecki; Stanley B Cohen; Michael A Bolognese; Grattan C Woodson; Alfred H Moffett; Munro Peacock; Paul D Miller; Samuel N Lederman; Charles H Chesnut; Douglas Lain; Alan J Kivitz; Donna L Holloway; Charlie Zhang; Mark C Peterson; Pirow J Bekker
Denosumab in postmenopausal women with low bone mineral density.
The New England journal of medicine 2006;354(8):821-31.
2006: Jean-Yves Reginster; Dieter Felsenberg; Cyrus Cooper; Jacob A Stakkestad; Paul D Miller; David L Kendler; Silvano Adami; Michael R McClung; Michael A Bolognese; Roberto Civitelli; Etienne Dumont; Bernard Bonvoisin; Robert R Recker; Pierre D Delmas
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(2):159-66.
2006: Ethel S Siris; Susan K Brenneman; Elizabeth Barrett-Connor; Paul D Miller; Shiva G Sajjan; Marc L Berger; Ya-Ting Chen
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(4):565-74.
2006: Paul D Miller; Stuart L Silverman; Deborah T Gold; Kathleen A Taylor; Peiqi Chen; Rachel B Wagman
Rationale, objectives and design of the Direct Analysis of Nonvertebral Fracture in the Community Experience (DANCE) study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(1):85-90.
2005: Mark P Ettinger; Dieter Felsenberg; Steven T Harris; Richard D Wasnich; Arne Skag; Valerie Hiltbrunner; Katie Wilson; Ralph C Schimmer; Paul D Miller
Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
The Journal of rheumatology 2005;32(10):1968-74.
2005: Paul D Miller
Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction.
Current osteoporosis reports 2005;3(3):103-10.
2005: Michael R McClung; Javier A San Martin; Paul D Miller; Roberto Civitelli; Francisco Bandeira; Molly Omizo; David W Donley; Gail P Dalsky; Erik Fink Eriksen
Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass.
Archives of internal medicine 2005;165(15):1762-8.
2005: Paul D Miller; William J Shergy; Jean-Jacques Body; Peiqi Chen; Mark E Rohe; John Krege
Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.
The Journal of rheumatology 2005;32(8):1556-62.
2005: Paul D Miller; Michael R McClung; Liviu Macovei; Jacob A Stakkestad; Marjorie Luckey; Bernard Bonvoisin; Jean-Yves Reginster; Robert R Recker; Claire Hughes; E Michael Lewiecki; Dieter Felsenberg; Pierre D Delmas; David L Kendler; Michael A Bolognese; Nicole Mairon; Cyrus Cooper
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(8):1315-22.
2005: Anthony B Hodsman; Douglas Charles Bauer; David W Dempster; Larry Dian; David A Hanley; Steven T Harris; David L Kendler; Michael R McClung; Paul D Miller; Wojciech P Olszynski; Eric Orwoll; Chui Kin Yuen
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
Endocrine reviews 2005;26(5):688-703.
2005: Paul D Miller
Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
Clinical therapeutics 2005;27(4):361-76.
2005: Paul D Miller; Marc C Hochberg; Lois E Wehren; Philip Ross; Richard D Wasnich
How useful are measures of BMD and bone turnover?
Current medical research and opinion 2005;21(4):545-54.
2005: Paul D Miller
Should low bone mass be treated?
International journal of fertility and women's medicine 2005;50(2):83-7.
2005: Charles H Chesnut; Mark P Ettinger; Paul D Miller; David J Baylink; Ronald Emkey; Steven T Harris; Richard D Wasnich; Nelson B Watts; Ralph C Schimmer; Robert R Recker
Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE.
Current medical research and opinion 2005;21(3):391-401.
2005: Paul D Miller
Treatment of metabolic bone disease in patients with chronic renal disease: a perspective for rheumatologists.
Current rheumatology reports 2005;7(1):53-60.
2005: Elizabeth Barrett-Connor; Ethel S Siris; Lois E Wehren; Paul D Miller; Thomas A Abbott; Marc L Berger; Arthur C Santora; Louis M Sherwood
Osteoporosis and fracture risk in women of different ethnic groups.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(2):185-94.
2004: Ethel S Siris; Susan K Brenneman; Paul D Miller; Elizabeth Barrett-Connor; Ya-Ting Chen; Louis M Sherwood; Thomas A Abbott
Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(8):1215-20.
2004: Paul D Miller
Pitfalls in bone mineral density measurements.
Current osteoporosis reports 2004;2(2):59-64.
2004: Paul D Miller; Suna Barlas; Susan K Brenneman; Thomas A Abbott; Ya-Ting Chen; Elizabeth Barrett-Connor; Ethel S Siris
An approach to identifying osteopenic women at increased short-term risk of fracture.
Archives of internal medicine 2004;164(10):1113-20.
2004: Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Bone mineral density thresholds for pharmacological intervention to prevent fractures.
Archives of internal medicine 2004;164(10):1108-12.
2004: Paul D Miller; John P Bilezikian; Chad Deal; Steven T Harris; Roberto Pa Ci
Clinical use of teriparatide in the real world: initial insights.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2004;10(2):139-48.
2004: John Yates; Elizabeth Barrett-Connor; Suna Barlas; Ya-Ting Chen; Paul D Miller; Ethel S Siris
Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.
Obstetrics and gynecology 2004;103(3):440-6.
2004: Paul D Miller; Thomas Schnitzer; Ronald Emkey; Eric Orwoll; Clifford Rosen; Mark P Ettinger; Kristel Vandormael; Anastasia G Daifotis
Weekly oral alendronic Acid in male osteoporosis.
Clinical drug investigation 2004;24(6):333-41.
2003: Paul D Miller
Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis.
Expert opinion on pharmacotherapy 2003;4(12):2253-8.
2003: Paul D Miller
Defining strategies for improving the identification and management of osteoporosis in the primary care setting.
International journal of fertility and women's medicine 2003;48(6):261-72.
2003: Paul D Miller
Bone mass measurements.
Clinics in geriatric medicine 2003;19(2):281-97, vi.
2002: Paul D Miller; Ethel S Siris; Elizabeth Barrett-Connor; Kenneth G Faulkner; Lois E Wehren; Thomas A Abbott; Ya-Ting Chen; Marc L Berger; Arthur C Santora; Louis M Sherwood
Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(12):2222-30.
2002: Paul D Miller; John P Bilezikian
Bone densitometry in asymptomatic primary hyperparathyroidism.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17 Suppl 2():N98-102.
2002: Susan L Greenspan; Diane L Schneider; Michael R McClung; Paul D Miller; Thomas J Schnitzer; Randi Bonin; Mary Elizabeth Smith; Paul T DeLucca; Glenn J Gormley; Mary E Melton
Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial.
Annals of internal medicine 2002;136(10):742-6.
2001: Ethel S Siris; Paul D Miller; Elizabeth Barrett-Connor; K G Faulkner; Lois E Wehren; Thomas A Abbott; Marc L Berger; Arthur C Santora; Louis M Sherwood
Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.
JAMA : the journal of the American Medical Association 2001;286(22):2815-22.
2001: Paul D Miller
Bisphosphonates for the prevention and treatment of corticosteroid-induced osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2001;12 Suppl 3():S3-10.
2001: Paul D Miller
New possibilities for diagnosis and treatment of osteoporosis.
International journal of fertility and women's medicine 2001;46(4):215-21.
2001: Susan L Greenspan; S Cheng; Paul D Miller; Eric Orwoll
Clinical performance of a highly portable, scanning calcaneal ultrasonometer.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2001;12(5):391-8.
2000: Paul D Miller; G Woodson; A A Licata; Mark P Ettinger; B Mako; Mary Elizabeth Smith; L Wang; S J Yates; Mary E Melton; J J Palmisano
Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms.
Clinical therapeutics 2000;22(12):1433-42.
2000: Susan L Greenspan; Steven T Harris; Henry G Bone; Paul D Miller; Eric Orwoll; Nelson B Watts; C J Rosen
Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis.
American family physician 2000;61(9):2731-6.
1999: Steven T Harris; Nelson B Watts; Harry K Genant; C D McKeever; T Hangartner; M Keller; Charles H Chesnut; J Brown; Erik Fink Eriksen; MS Hoseyni; D W Axelrod; Paul D Miller
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
JAMA : the journal of the American Medical Association 1999;282(14):1344-52.
1999: Paul D Miller; C Zapalowski; C A Kulak; John P Bilezikian
Bone densitometry: the best way to detect osteoporosis and to monitor therapy.
The Journal of clinical endocrinology and metabolism 1999;84(6):1867-71.
1999: Paul D Miller; Jacques P Brown; Ethel S Siris; MS Hoseyni; D W Axelrod; Pirow J Bekker
A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
The American journal of medicine 1999;106(5):513-20.
1999: Paul D Miller
The use of risedronate in Paget's disease.
Bone 1999;24(5 Suppl):91S-92S.
1999: Paul D Miller; D T Baran; J P Bilezikian; S L Greenspan; R Lindsay; Lawrence B. Riggs; Nelson B Watts
Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 1999;2(3):323-42.
1998: Ethel S Siris; AA Chines; R D Altman; Jacques P Brown; CC Johnston; R Lang; Michael R McClung; L E Mallette; Paul D Miller; W G Ryan; Frederick R Singer; Joseph R Tucci; Rachelle A Eusebio; Pirow J Bekker
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1998;13(6):1032-8.
1998: Paul D Miller; Sydney Lou Bonnick; C C Johnston; Michael Kleerekoper; R L Lindsay; Louis M Sherwood; E S Siris
The challenges of peripheral bone density testing: which patients need additional central density skeletal measurements?
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 1998;1(3):211-7.
1997: Paul D Miller; Nelson B Watts; A A Licata; Steven T Harris; Harry K Genant; Richard D Wasnich; Philip Ross; Rebecca D Jackson; MS Hoseyni; S L Schoenfeld; D J Valent; Charles H Chesnut
Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
The American journal of medicine 1997;103(6):468-76.
1996: Paul D Miller
Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.
The British journal of clinical practice 1996;50(1):23-31.
1994: Susan M Ott; G C Woodson; W E Huffer; Paul D Miller; Nelson B Watts
Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis.
The Journal of clinical endocrinology and metabolism 1994;78(4):968-72.
1993: Steven T Harris; Nelson B Watts; Rebecca D Jackson; Harry K Genant; R D Wasnich; P Ross; Paul D Miller; A A Licata; Charles H Chesnut
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
The American journal of medicine 1993;95(6):557-67.
1990: Nelson B Watts; Steven T Harris; Harry K Genant; R D Wasnich; Paul D Miller; Rebecca D Jackson; A A Licata; P Ross; G C Woodson; M J Yanover
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.
The New England journal of medicine 1990;323(2):73-9.